- Medtronic Plc MDT is recalling HeartWare HVAD System batteries because they may experience electrical faults that cause the system to fail unexpectedly.
- The HeartWare Ventricular Assist Device (HVAD) System is used to help the heart continue to pump blood to the rest of the body.
- The HVAD system is used as a bridge to cardiac transplants in patients at risk of death from end-stage left ventricular heart failure, for heart tissue recovery, or as destination therapy (DT) in patients for whom heart transplants are not planned.
- The system operates using power from either AC or DC electricity or batteries.
- If the battery fails and the patient is unable to replace the failed battery with a charged, working battery or with AC or DC power, the HVAD may stop working, leading to serious injury or death.
- Medtronic reports 1,159 complaints, six injuries, and one death related to this issue.
- Medtronic will recall over 23,000 Medtronic HVAD Batteries distributed after January 2009.
- Last week, the company announced to recall Cobalt/Crome Implantable Cardioverter Defibrillators (ICDs) and Resynchronization Therapy Defibrillators (CRT-Ds) after receiving reports of devices with short circuit protection (SCP) alert resulting in reduced-energy electric shock delivery, instead of delivering the second phase of high voltage therapy.
- Medtronic's ICDs and CRT-Ds are implantable cardiac devices that monitor and regulate heart rate and rhythm.
- Price Action: MDT shares are up 2.37% at $91.40 on the last check Thursday.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in
